#NOGG2017

Updated 2017

About NOGG

The National Osteoporosis Guideline Group* (NOGG) comprises a multidisciplinary group including patient representation and professionals involved in the care of people with osteoporosis. It was established in 2007 to provide a clinical guideline for the management of men and women at high fracture risk, using the output from the FRAX calculator.
The current NOGG Guideline has been produced with the support of the Bone Research Society, British Geriatric Society, British Orthopaedic Association, National Osteoporosis Society, Osteoporosis 2000 and Osteoporosis Dorset. Primary Care Rheumatology Society, Royal College of General Practitioners, Royal Pharmaceutical Society and Society of Endocrinology.
It has also been approved by the IOF Committee of Scientific Advisors.

Guideline Development Writing Group

The guideline development writing group was composed of two committees, the Guideline Development Group and the Expert Advisory Group. Members of both committees contributed to the content of the guideline, but voting on the recommendations was restricted to the Guideline Development Group.
No funding source/body was involved in the development of this guideline.

Guideline Development Group

Juliet Compston: (chair). Professor Emeritus of Bone Medicine, Cambridge Biomedical Campus, Cambridge UK
Alun Cooper: Primary Care Physician, Clinical Lead for Crawley Fracture Liaison Service, Crawley, Sussex
Celia Gregson: Consultant Senior Lecturer, Musculoskeletal Research Unit, University of Bristol & Honorary Consultant Geriatrician, Royal United Hospital NHS Foundation Trust, Bath, UK
Suzanne Hewitt: Patient representative (stepped down 3/2016)
David Reid: Emeritus Professor of Rheumatology, University of Aberdeen
Peter Selby: Endocrinologist, Consultant Physician and Honorary Clinical Professor of Metabolic Bone Disease, University of Manchester
Fizz Thompson, Clinical and Operations Manager, National Osteoporosis Society
Anne Thurston: Head of Policy, National Osteoporosis Society
Nic Vine: Public and patient representative
John Kanis: (ex officio) Professor Emeritus, Centre for Metabolic Diseases, University of Sheffield Medical School, Sheffield, United Kingdom and Professor, Institute for Health and Aging, Catholic University of Australia, Melbourne, Australia

Expert Advisory Group

Cyrus Cooper: Professor of Rheumatology, MRC Lifecourse Epidemiology Unit, University of Southampton and Professor of Musculoskeletal Science, University of Oxford
Neil Gittoes: Consultant & Honorary Professor of Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham & Birmingham Health Partners
Nicholas Harvey: Professor of Rheumatology and Clinical Epidemiology, and Honorary Consultant Rheumatologist, MRC Lifecourse Epidemiology Unit, University of Southampton
Sally Hope: Primary Care Physician, Clinical Assistant, Metabolic Bone, Nuffield Orthopaedic Hospital, Oxford
John Kanis: Professor Emeritus, Centre for Metabolic Diseases, University of Sheffield Medical School, Sheffield, United Kingdom and Professor, Institute for Health and Aging, Catholic University of Australia, Melbourne, Australia
Eugene McCloskey: Professor in Adult Bone Disease and Honorary Consultant, University of Sheffield and Sheffield Director of the Centre for Integrated research in Musculoskeletal Ageing (CIMA), University of Sheffield
Kenneth Poole: Rheumatologist, Reader in Metabolic Bone Disease and Honorary Consultant Physician, Cambridge Biomedical Campus

Conflicts of interest

A file containing all of the relevant conflict of interests of the members of the two Committees above can be accessed by clicking here.

Centre for Metabolic Bone Diseases, University of Sheffield, UK